Pharmaceuticals
-
Statins reduce cardiovascular disease risk in older people – review
Patients over the age of 75 benefit from taking statins to reduce their risk of developing cardiovascular disease, according to an analysis published today. Read more
-
New doubts over aspirin and cardiovascular disease prevention
The risks from taking aspirin to prevent cardiovascular incidents may outweight the benefits for healthy patients, according to a new systematic review. Read more
-
Macrophage link to hypertension
Macrophages in the immune system may have a key role in hypertension, according to a project in Edinburgh, UK. Read more
-
Combination therapy converts cancer cells into fat cells
Scientists have found a drug combination that can turn breast cancer cells into fat cells, it has been announced. Read more
-
HRT tablets highest VTE risk
Women who take hormone replacement therapy in tablet form may face an increased risk of venous thromboembolism, according to a large UK study published today. Read more
-
Neoadjuvant treatment complication studied
A recent study has identified a new link between chemotherapy for breast cancer and the spread of the disease. Read more
-
Hope for new lung cancer therapy
UK researchers are investigating the use of drugs commonly used for breast cancer to treat drug-resistant lung cancer. Read more
-
Exercise may be best medicine for hypertension
Exercise interventions may be as effective as most medication for hypertension, researchers say today. Read more
-
Pregnancy pain relief guidance published
Women who need pain relief during pregnancy and while breast-feeding should rely on paracetamol so far as possible, new guidance says today. Read more
-
Statin adherence and dose important for high risk patients
Patients at high risk from cardiovascular disease should be prescribed high doses of statins and adherence monitored closely, according to a new observational analysis. Read more
